BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31277797)

  • 1. Aflibercept for Radiation Maculopathy Study: A Prospective, Randomized Clinical Study.
    Murray TG; Latiff A; Villegas VM; Gold AS
    Ophthalmol Retina; 2019 Jul; 3(7):561-566. PubMed ID: 31277797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study.
    Finger PT; Chin KJ; Semenova EA
    Eur J Ophthalmol; 2016; 26(1):60-6. PubMed ID: 26391167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aflibercept for Radiation Maculopathy (ARM Study): Year-2 Extension of a Prospective Clinical Study.
    Murray TG; Latiff A; Villegas VM; Gold AS
    J Vitreoretin Dis; 2021; 5(3):232-238. PubMed ID: 37006513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma.
    Mashayekhi A; Rojanaporn D; Al-Dahmash S; Shields CL; Shields JA
    Eur J Ophthalmol; 2014; 24(2):228-34. PubMed ID: 23934823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT AT 2-MONTH INTERVALS REDUCES FOVEAL AVASCULAR ZONE ENLARGEMENT AND VISION LOSS IN RADIATION MACULOPATHY: A Pilot Study.
    Daruich A; Matet A; Schalenbourg A; Zografos L
    Retina; 2019 Aug; 39(8):1519-1526. PubMed ID: 29746413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Trial of Monthly Versus As-Needed Intravitreal Ranibizumab for Radiation Retinopathy-Related Macular Edema: 1-Year Outcomes.
    Schefler AC; Fuller D; Anand R; Fuller T; Moore C; Munoz J; Kim RS;
    Am J Ophthalmol; 2020 Aug; 216():165-173. PubMed ID: 32278771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of ziv-aflibercept in retinal diseases.
    Mansour AM; Ashraf M; Dedhia CJ; Charbaji A; Souka AAR; Chhablani J
    Br J Ophthalmol; 2017 Oct; 101(10):1374-1376. PubMed ID: 28270485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial.
    Dugel PU; Jaffe GJ; Sallstig P; Warburton J; Weichselberger A; Wieland M; Singerman L
    Ophthalmology; 2017 Sep; 124(9):1296-1304. PubMed ID: 28551167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal aflibercept for the treatment of radiation-induced macular edema after ruthenium 106 plaque radiotherapy for choroidal melanoma.
    Fallico M; Reibaldi M; Avitabile T; Longo A; Bonfiglio V; Chronopoulos A; Caltabiano R; Spatola C; Russo A
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1547-1554. PubMed ID: 31081526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study.
    Garweg JG; Stefanickova J; Hoyng C; Schmelter T; Niesen T; Sowade O; Sivaprasad S;
    Ophthalmol Retina; 2019 Jul; 3(7):567-575. PubMed ID: 31080168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma.
    Shah SU; Shields CL; Bianciotto CG; Iturralde J; Al-Dahmash SA; Say EAT; Badal J; Mashayekhi A; Shields JA
    Ophthalmology; 2014 Jan; 121(1):269-275. PubMed ID: 24139123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).
    Gupta A; Muecke JS
    Retina; 2008; 28(7):964-8. PubMed ID: 18698298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INTRAVITREAL DEXAMETHASONE IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO PLAQUE BRACHYTHERAPY IN CHOROIDAL MELANOMA.
    Caminal JM; Flores-Moreno I; Arias L; Gutiérrez C; Piulats JM; Català J; Rubio MJ; Cobos E; García P; Pera J; Giralt J; Arruga J
    Retina; 2015 Sep; 35(9):1890-7. PubMed ID: 26035401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization: The MYRROR Study.
    Ikuno Y; Ohno-Matsui K; Wong TY; Korobelnik JF; Vitti R; Li T; Stemper B; Asmus F; Zeitz O; Ishibashi T;
    Ophthalmology; 2015 Jun; 122(6):1220-7. PubMed ID: 25745875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.
    Dugel PU; Koh A; Ogura Y; Jaffe GJ; Schmidt-Erfurth U; Brown DM; Gomes AV; Warburton J; Weichselberger A; Holz FG;
    Ophthalmology; 2020 Jan; 127(1):72-84. PubMed ID: 30986442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration.
    Chang AA; Li H; Broadhead GK; Hong T; Schlub TE; Wijeyakumar W; Zhu M
    Ophthalmology; 2014 Jan; 121(1):188-192. PubMed ID: 24144450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma.
    Shields CL; Demirci H; Dai V; Marr BP; Mashayekhi A; Materin MA; Manquez ME; Shields JA
    Retina; 2005; 25(7):868-74. PubMed ID: 16205566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durability of every-8-week aflibercept maintenance therapy in treatment-experienced neovascular age-related macular degeneration.
    Dans KC; Freeman SR; Lin T; Meshi A; Olivas S; Cheng L; Amador-Patarroyo MJ; Freeman WR
    Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):741-748. PubMed ID: 30806775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Baseline Retinal Nonperfusion and Macular Retinal Capillary Nonperfusion on Outcomes in the COPERNICUS and GALILEO Studies.
    Feltgen N; Ogura Y; Boscia F; Holz FG; Korobelnik JF; Brown DM; Heier JS; Stemper B; Rittenhouse KD; Asmus F; Ahlers C; Vitti R; Saroj N; Mitchell P
    Ophthalmol Retina; 2019 Jul; 3(7):553-560. PubMed ID: 31277796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age.
    Chang M; Dalvin LA; Mazloumi M; Martin A; Yaghy A; Yang X; Bakhtiari S; Li L; Jennings E; Mashayekhi A; Shields CL
    Asia Pac J Ophthalmol (Phila); 2020; 9(1):29-38. PubMed ID: 31990743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.